CXCR antagonist AMD 3465 Hexahydrobromide, Purity ≥98%

Synonym: AMD 3465 hexahydrobromide; 185991-07-5; AMD 3465 (Hexahydrobromide); GENZ-644494 (hexahydrobromide); N-(4-((1,4,8,11-Tetraazacyclotetradecan-1-yl)methyl)benzyl)-1-(pyridin-2-yl)methanamine hexahydrobromide; N-[[4-(1,4,8,11-Tetraazacyclotetradec-1-ylmethyl)phenyl]methyl]-2-pyridinemethanamine hexahydrobromide; CXCR antagonist

MDL: MFCD20926342
CAS Number: 185991-07-5
Compound CID: 9897616

Product Size

10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

AMD 3465 Hexahydrobromide, soluble in DMSO and water and insoluble in ethanol, is a potent, selective CXCR4 antagonist. It targets 12G5 mAb-CXCR4, CXCL12AF647-CXCR4, HIV-2 (EHO), HIV-2 (ROD), X4 HIV-1 (HE), X4 HIV-1 (IIIB), X4 HIV-1 (NL4.3), X4 HIV-1 (NL4.3AMD3100), and X4 HIV-1 (RF).

Molecular Weight

896.07

Molecular Formula

C₂₄H₃₈N₆.6HBr

Targets

12G5 mAb-CXCR4: 0.75 nM; CXCL12AF647-CXCR4: 18 nM (In SupT1 cells); HIV-2 (EHO); HIV-2 (ROD): 12.3 nM (In MT-4 cells); X4 HIV-1 (HE): 9.8 nM (In MT-4 cells); X4 HIV-1 (IIIB): 12.3 nM (In MT-4 cells); X4 HIV-1 (NL4.3): 6.1 nM (In MT-4 cells); X4 HIV-1 (NL4.3AMD3100): 2822 nM (In MT-4 cells); X4 HIV-1 (RF): 7.4 nM (In MT-4 cells)

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 2 mg/mL (2.23 mM); Water: 83 mg/mL (92.62 mM); Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

AMD 3465 Hexahydrobromide can be used to explore its application as a CXCR4 antagonist in cancer and HIV research.